TriVascular Technologies (TRIV) Tops Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to TriVascular Technologies (TRIV) Tops Q3 EPS by 5c

TriVascular Technologies, Inc. Reports Third Quarter Financial Results

November 9, 2015 4:01 PM EST

SANTA ROSA, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ: TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, today reported financial results for the third quarter ended September 30, 2015.

Recent Accomplishments:

Third quarter revenue of $9.5 million, up 20.0% over the third quarter of 2014 as reported, and 23.4% on a constant currency basis Third quarter gross margin of 63.5%, an increase from 57.2% in the third quarter of 2014 4-year Ovation Clinical data presented at the November VIVA conference Interim LIFE Study data highlighting clinical & economic benefits of Ovation platform... More